Skip to main content

Short Bowel Syndrome clinical trials at UCLA

2 in progress, 0 open to eligible people

Showing trials for
  • Long-term Safety of Apraglutide in Short Bowel Syndrome.

    Sorry, in progress, not accepting new patients

    The primary objective of the trial is to assess long-term safety and tolerability of apraglutide in subjects with SBS-IF.

    Los Angeles, California and other locations

  • Apraglutide in SBS-IF

    Sorry, in progress, not accepting new patients

    The primary objective of the trial is the confirmation of the efficacy of apraglutide to evaluate the efficacy of weekly subcutaneous apraglutide in reducing parenteral support dependency.

    Los Angeles, California and other locations

Our lead scientists for Short Bowel Syndrome research studies include .

Last updated: